Cargando…
Reduction of cytotoxicity of benzalkonium chloride and octenidine by Brilliant Blue G
The irritative effects of preservatives found in ophthalmologic solution, or of antiseptics used for skin disinfection is a consistent problem for the patients. The reduction of the toxic effects of these compounds is desired. Brilliant Blue G (BBG) has shown to meet the expected effect in presence...
Autores principales: | Bartok, Melinda, Tandon, Rashmi, Alfaro-Espinoza, Gabriela, Ullrich, Matthias S., Gabel, Detlef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553885/ https://www.ncbi.nlm.nih.gov/pubmed/26417355 http://dx.doi.org/10.17179/excli2014-556 |
Ejemplares similares
-
Aspergilli Response to Benzalkonium Chloride and Novel-Synthesized Fullerenol/Benzalkonium Chloride Nanocomposite
por: Unković, Nikola, et al.
Publicado: (2015) -
Influence of
in Vitro Assay Setup on the Apparent
Cytotoxic Potency of Benzalkonium Chlorides
por: Groothuis, Floris A., et al.
Publicado: (2019) -
Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost
por: García-Feijoo, Julian, et al.
Publicado: (2016) -
Anti-Prion Activity of Brilliant Blue G
por: Iwamaru, Yoshifumi, et al.
Publicado: (2012) -
Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops?
por: Louati, Y, et al.
Publicado: (2012)